R&D
The conflict in the Middle East is exposing dangerous prepar...
If the conflict persists, the risk of widespread medicine shortages becomes increasingly real.
Digital
From static documents to strategic capability: The case for ...
Protocol documentation will become protocol ingestion – an approach that’s automated, consistent, and intelligent.
R&D
Neuroplasticity modulators as innovative potential disease-m...
In September last year, we reported Servier had advanced its emerging neurology pipeline into the clinical trials stage by licensing a drug for the rare genetic disorder Fragile X syndrome
Market Access
Highlights from the UK’s December 2025 VPAG metrics
Leela Barham looked at the latest metrics used to monitor the UK’s voluntary pricing scheme.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
